Life Sciences: What's new in Europe

Read more about the recent developments in the life sciences sector.

Content :

• Antitrust: The Servier Case: The Game isn't Over Yet
• Corportate and Securities: Overview of financing options for French biotech companies
• Regulatory: Health is priceless; supply shortages come at a high price, as determined by the sanctions imposed by the French Health Agency.
• Antitrust: Illumina/Grail: EU Court overturns approach to "killer acquisitions"
• Regulatory: Healthcare Center Investor Saga: French Court Rules on Minority Shareholding by Non-Healthcare Professionals